A first of its kind, privately funded program with a focus on reducing PTSD suicides and accidental overdose deaths caused by prescription pain medication in our Veterans and the general public. The VFCF-50 program uses DNA sequencing to determine-and verify the identity of-cannabis strains effective in reducing or alleviating the symptoms of PTSD and Chronic Pain. Performed in collaboration with Potent LTD. and Medicinal Genomics. The VFCF-50 case study represents the 22+ Veterans that take their own life each day and the more than 25 lives lost in our Veteran community each day from accidental overdose.